- Investing Ideas
- Spanish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Spanish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
2
1 new
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Oryzon Genomics
Market Cap: €244.7m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders.
ORY
€2.95
7D
3.6%
1Y
8.8%
Labiana Health
Market Cap: €52.7m
Develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally.
New
LAB
€6.25
7D
-5.3%
1Y
58.6%